Reactive arthritis

Current Opinion in Rheumatology

Volumn 11, Issue 4, 1999, Pages 238-243

  Sieper, Joachim ^a   Braun, Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD CELL; CHLAMYDIA TRACHOMATIS; DISEASE ASSOCIATION; ENTEROBACTER; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE RESPONSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY; YERSINIA;

ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; HUMANS;

EID: 0032840981     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199907000-00003     Document Type: Article

References (48)

1. 1 Sieper J, Braun J: Pathogenesis of spondyloarthropathies: persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995, 38:1547-1554.
2. 2 Sieper J, Kingsley G: Recent advances in the pathogenesis of reactive arthritis. Immunol Today 1996, 17:160-163.
3. 3 Wilkinson NZ, Kingsley GH, Sieper J, Braun J, Ward ME: Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum 1998, 41;845-854. C. trachomatis was detected in approximately 30% of patients with undifferentiated oligoarthritis in synovial fluid. An inverse correlation was found between the detection of chlamydiae and specific lymphocyte proliferation, indicating that a weak T-cell response contributes to bacterial persistence.
4. 4 Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995,38:1005-1013.
5. 5 Gerard HC, Branigan PJ, Arayssi T, Klippel JH, Schumacher HR, Hudson AP: Viability of Chlamydia pneumoniae in synovial tissue of arthritis patients. Arthritis Rheum 1996, 39(suppl):183.
6. 6 Braun J, Tuszewski M, Eggens U, Mertz A, Schauer-Petrowskaja C, Doring E, et al.: Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases: I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997, 24:1092-1100.
7. 7 Gerard HC, Branigan PJ, Schumacher HR Jr, Hudson AP: Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998, 25:734-742. C trachomatis RNA was detected in synovial membrane, indicating that chlamydiae are alive. The hsp60, but not the major outer membrane protein (omp 1), was transcribed.
8. 8 Nikkari S, Merilahti-Palo R, Saario R, Soderstrom KO, Granfors K, Skurnik M, Toivanen P: Yersinia-triggered reactive arthritis: use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992, 35:682-687.
9. 9 Wilkinson N, Kingsley G, Jones H, Sieper J, Braun J, Ward M: The detection of DNA from a range of bacterial species in the joint of patients with a variety of arthritides using a nested, broad-range PCR. Rheumatology 1999, 38:260-266.
10. 10 Nikkari S, Rantakokko K, Ekman P, Mottonen T, Leirisalo-Repo M, Virtala M, et al.: Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999, 42:84-89. No Salmonella DNA could be found in synovial fluid despite the detection of bacterial products from Salmonella sp. by other methods.
11. 11 Granfors K, Merilahti-Palo R, Luukkainen R, Mottonen T, Lahesmaa R, Probst P, et al.: Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998, 41:855-862. Bacterial products from yersiniae were found in peripheral blood and synovial fluid cells from patients with Yersinia-induced enteritis and arthritis for up to 4 years, indicating that yersiniae probably survive somewhere in the body.
12. 12 Toivanen A, Lahesmaa-Rantala R, Vuento R, Granfors K: Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients. Ann Rheum Dis 1987, 46:898-901.
13. 13 Kuipers JG, Jurgens-Saathoff B, Bialowons A, Wollenhaupt J, Kohler L, Zeidler H: Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum 1998, 41:1894-1895. C trachomatis was detected in peripheral blood cells by polymerase chain reaction in two patients with early Chlamydia-induced arthritis, indicating that chlamydiae are transported intracellularly via the blood into the joint.
14. 14 Wilbrink B, van der Heijden IM, Schouls LM, van Embden JD, Hazes JM, Breedveld FC, Tak PP: Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum 1998, 41:535-543.
15. 15 Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, Sieper J: Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997, 40:1788-1797.
16. 16 Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, et al.: T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997, 40:69-79.
17. 17 Braun J, Yin Z, Spiller l, Siegert S, Rudwaleit M, Liu L, Radbruch A, Sieper J: A low TNFα-secretion of peripheral blood mononuclear cells but no other T helper 1 or 2 cytokines correlates with chronicity in reactive arthritis. Arithis Rheum, in press.
18. 18 Höhler T, Schaper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E: Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998, 41:1489-1492. A TNF-α promotor allele associated with a lower TNF-α secretion was found less frequently in patients with ankylosing spondylitis than in controls, indicating that a TNF-α defect could play a pathogenetic role for the whole group of spondyloarthropathies.
19. 19 Deane KH, Jocock RM, Pearce JH, Gaston JS: Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. Clin Exp Immunol 1997, 109:439-445.
20. 20 Mertz AK, Ugrinovic S, Lauster R, Wu P, Grolms M, Bottcher U, et al.: Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heatshock protein 60 drives a major immune response. Arthritis Rheum 1998, 41:315-326. The Yersinia-derived hsp60 was identified as an immunodominant antigen for synovial fluid T cells in patients with Yersinia-induced arthritis.@refs:.
21. 21 Ugrinovic S, Mertz A, Wu P, Braun J, Sieper J: A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J Immunol 1997, 159:5715-5723.
22. 22 Mertz A, Wu P, Rudwaleit M, Braun J, Sieper J: Synovial T cell response to the heat shock protein 60 of Yersinia enterocolitica in Yersinia-arthritis patients: epitope analysis and cytokine secretion profile. Arthritis Rheum 1998, 41(suppl):131.
23. 23 Zhou M, Sayad A, Simmons WA, Jones RC, Maika SD, Satumtira N, et al.: The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 1998, 188:877-886.\ In the model of HLA-B27 transgenic rats, a peptide derived from the influenza nucleoprotein, which is a strong binder to HLA-B27 improved arthritis, indicating that such an approach could be a new treatment strategy.
24. 24 Fendler C, Braun J, Eggens U, Laitko S, Sorensen H, Distler A, Sieper J: Bacteria-specific lymphocyte proliferation in peripheral blood in reactive arthritis and related diseases. Br J Rheumatol 1998, 37:520-524.
25. 25 Fendler C, Wu P, Eggens U, Laitko S, Sorensen H, Distler A, et al.: Longitudinal investigation of bacterium-specific synovial lymphocyte proliferation in reactive arthritis and lyme arthritis. Br J Rheumatol 1998, 37:784-788.
26. 26 Beacock-Sharp H, Young JL, Gaston JS: Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients. Ann Rheum Dis 1998, 57:100-106.
27. 27 Inman RD, Chiu B: Synoviocyte-packaged Chlamydia trachomatis induces a chronic aseptic arthritis. J Clin Invest 1998, 102:1776-1782. A new interesting animal model of Chlamydia-induced arthritis.
28. 28 Laitio P, Virtala M, Salmi M, Pelliniemi LI, Yu DT, Granfors K: HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells, Eur J Immunol 1997, 27:1331-1338.
29. 29 Ortiz-Alvarez O, Yu DT, Petty RE, Finlay BB: HLA-B27 does not affect invasion of arthritogenic bacteria into human cells. J Rheumatol 1998, 25:1765-1771.
30. 30 Boyer GS, Templin DW, Bowler A, Lawrence RC, Everett DF, Heyse SP, et al.: A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a community-wide epidemioiogic study. Has the classic case misled us? Arch Intern Med 1997, 157:2111-2117.
31. 31 Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J: Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998, 41:58-67. A high prevalence of SpAs was found investigating HLA-B27-positive and HLA-B27-negative blood donors.
32. 32 Kvien T, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, Thoen J: Reactive arthritis: Incidence, triggering agents and clinical presentation. J Rheumatol 1994, 21:115-122.
33. 33 Mattila L, Leirisalo-Repo M, Pelkonen P, Koskimies S, Granfors K, Siitonen A: Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J Infect 1998, 36:289-295.
34. 34 Pacheco-Tena C, Burgos-Vargas R, Vazquez-Mellado J, Cazarin J, Perez-Diaz JA: A proposal for the classification of patients to enter clinical and experimental studies on reactive arthritis: a study based on a review of inclusion criteria as appeared in scientific articles. J Rheumatol, in press.
35. 35 Sieper J, Braun J: Problems and advances in the diagnosis of reactive arthritis. J Rheumatol, in press.
36. 36 Bas S, Cunningham T, Kvien TK, Glennas A, Melby K, Vischer TL: Synovial fluid and serum antibodies against Chlamydia in different forms of arthritis: intra-articular IgA production in Chlamydia sexually acquired reactive arthritis. Br J Rheumatol 1996, 35:548-552.
37. 37 Bas S, Cunningham T, Kvien TK, Glennas A, Melby K, Vischer TL: The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. Br J Rheumatol 1996, 35:542-547.
38. 38 Bas S, Vischer TL: Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis. Br J Rheumatol 1998, 37:1054-1059. The serology of Chlamydia-induced arthritis was carefully investigated using Chlamydia-derived antigens instead of whole bacteria.
39. 39 Bollow M, Biedermann T, Kannenberg J, Paris S, Schauer-Petrowski C, Minden K, et al.: Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J Rheumatol 1998, 25:556-564. In children with different forms of SpAs, sacroiliitis could be detected by magnetic resonance imaging even in the absence of low back pain.
40. 40 McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy. Arthritis Rheum 1998, 41:694-700. These authors draw attention to the fact that, based on magnetic resonance imaging of knee arthritis, enthesitis is frequently found in peripheral joints and they hypothesize that enthesitis might come first and synovitis might be secondary to the enthesitis.
41. 41 McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137-1140.
42. 42 Sieper J, Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Hiepe F, et al.: No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum, in press.
43. 43 Lauhio A, Leirisalo-Repo M, Lahdevirta J, Saikku P, Repo H: Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991, 34:6-14.
44. 44 Wollenhaupt J, Hammer M, Pott HG, Zeidler H: A double-blind, placebo-controlled comparison of 2 weeks versus 4 months treatment with Doxycycline in Chlamydia-induced reactive arthritis. Arthritis Rheum 1997, 40(suppl):143.
45. 45 Sieper J, Braun J: Treatment of reactive arthritis with antibiotics [editorial]. Br J Rheumatol 1998, 37:717-720.
46. 46 Bardin T, Enel C, Cornelis F, Salski C, Jorgensen C, Ward R, Lathrop GM: Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992, 35:190-194.
47. 47 Locht H, Kihlstrom E, Lindstrom FD: Reactive arthritis after Salmonella among medical doctors-study of an outbreak. J Rheumatol 1993, 20:845-848.
48. 48 Buchs N, Chevrel G, Miossec P: Bacillus Calmette-Guerin induced aseptic arthritis: an experimental model of reactive arthritis [editorial]. J Rheumatol 1998, 25:1662-1665. The authors report that, in patients treated with Bacillus Calmette-Guèrin intravesically for bladder cancer, an oligoarthritis can occur. Most interestingly, 61% of these patients were HLA-B27 positive.